T1	HMM 280 299	efficacy and safety
T2	HMM 899 929	rates of retinitis progression
T3	HMM 1256 1352	rates of increase in retinal area involved by CMV, visual field loss, or visual acuity outcomes.
T4	HMM 1357 1371	mortality rate
T5	HMM 1487 1496	mortality
T6	HMM 1651 1666	mortality rates
T7	HMM 1830 1844	mortality rate
T8	HMM 1922 1936	mortality rate
T9	HMM 2230 2241	ineffective
T10	HMM 2282 2296	mortality rate
